News Conference News ESC 2024 OCCUPI: OCT Guidance Improves Outcomes in Complex PCI Shelley Wood September 03, 2024
News Conference News ESC 2024 SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients Michael O'Riordan September 02, 2024
News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News DES Best for In-Stent Restenosis, but DCBs Also Viable Michael O'Riordan August 13, 2024
News Daily News Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery Michael O'Riordan July 11, 2024
News Daily News ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI Michael O'Riordan July 01, 2024
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Daily News AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care L.A. McKeown May 17, 2024
News Conference News EuroPCR 2024 Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS Yael L. Maxwell May 15, 2024
News Conference News EuroPCR 2024 NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD Michael O'Riordan May 14, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Daily News Certain Periprocedural MIs Don’t Matter, New Data Allege Michael O'Riordan May 09, 2024
News Daily News Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI Michael O'Riordan March 26, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Daily News Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial Michael O'Riordan December 27, 2023